AVNT.NYSEAvient CORP

Form 4: Avient Corp Director William A. Wulfsohn Reports Acquisition of Shares Through Dividend Reinvestment

Sentiment:

SEC Form 4 Filing


Director William A. Wulfsohn reported the acquisition of 808 shares of Avient Corp through a dividend reinvestment in the Deferred Compensation Plan.

Summary

  • On March 29, 2024, William A. Wulfsohn, a director of Avient Corp, acquired 808 shares of common stock through a dividend reinvestment.
  • The shares were acquired through the Avient Corporation Deferred Compensation Plan for Non-Employee Directors.
  • Following the transaction, Wulfsohn beneficially owns 52,488.64 shares through the Deferred Comp Plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director's acquisition of shares through dividend reinvestment suggests confidence in the company's future, but it's a routine transaction.

Positives

  • The acquisition of shares through dividend reinvestment indicates a continued investment in the company by a director.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates a director's continued investment in the company through dividend reinvestment, which is a common practice.

Comparison to Industry Standards

  • Tracking insider transactions is a common practice in financial analysis.
  • Comparing the volume and frequency of insider transactions at Avient Corp to those of its peers (e.g., LyondellBasell, Dow, DuPont) can provide insights into management's confidence and alignment with shareholder interests.
  • Dividend reinvestment programs are a standard offering in many companies, and the participation of directors is generally viewed positively.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it signals confidence from a company director.

Key Dates

DateDescription
October 11, 2011Date of original Power of Attorney filing with the SEC.
January 24, 2024Date of Instrument of Substitution of Attorney-in-Fact.
March 29, 2024Date of transaction: acquisition of shares through dividend reinvestment.
April 01, 2024Date of signature on the report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.